Your browser doesn't support javascript.
loading
Use of adenovirus type-5 vector vaccines in COVID-19: potential implications for metabolic health?
Tsilingiris, Dimitrios; Vallianou, Natalia G; Karampela, Irene; Muscogiuri, Giovanna; Dalamaga, Maria.
Affiliation
  • Tsilingiris D; First Department of Propedeutic Internal Medicine, School of Medicine, Laiko General Hospital, National and Kapodistrian University of Athens, Athens, Greece - tsilingirisd@gmail.com.
  • Vallianou NG; First Department of Internal Medicine, Evangelismos General Hospital, Athens, Greece.
  • Karampela I; Second Department of Critical Care, Medical School, Attikon General University Hospital, National and Kapodistrian University of Athens, Athens, Greece.
  • Muscogiuri G; Unit of Endocrinology, Department of Clinical Medicine and Surgery, School of Medicine, University of Naples Federico II, Naples, Italy.
  • Dalamaga M; Unit of Endocrinology, Department of Clinical Medicine and Surgery, School of Medicine, Centro Italiano per la Cura e il Benessere del Patiente con Obesità (CIBO), University of Naples Federico II, Naples, Italy.
Minerva Endocrinol (Torino) ; 47(3): 264-269, 2022 09.
Article in En | MEDLINE | ID: mdl-35621112
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vaccines / Adenovirus Vaccines / COVID-19 Limits: Humans Language: En Journal: Minerva Endocrinol (Torino) Year: 2022 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vaccines / Adenovirus Vaccines / COVID-19 Limits: Humans Language: En Journal: Minerva Endocrinol (Torino) Year: 2022 Document type: Article